Abstract
In this investigation, we have designed and synthesized an amphiphilic co-polymer with hyper-branched poly(amine-ester) and polylactide (HPAE-co-PLA) to generate nanoparticles (NPs). These have been used to encapsulate a highly active hydrophobic anti-tumor agent, 2-benzoylpyridine 4-ethyl-3-thiosemicarbazone (Bp4eT). Encapsulation in NPs was done in an effort to increase the anti-tumor activity of this agent by facilitating its delivery to tumor cells. We have also examined and optimized the formulation parameters of the NPs that alter their drug-loading capacity and their physical, chemical and biological properties. The resulting NPs exhibited high Bp4eT-loading capacity and substantial stability in aqueous solution. In vitro drug release studies demonstrated a controlled drug release profile with increased release at acidic pH. Anti-tumor proliferation assays showed that both free drug and drug-encapsulated NPs markedly inhibited tumor cell proliferation in a time- and concentration-dependent manner. Direct microscopic observation revealed that the fluorescent NPs were taken up by cells and localized, in part, in organelles consistent with lysosomes. These results demonstrate a feasible application of the amphiphilic hyper-branched co-polymer, HPAE-co-PLA, as nanocarriers for intracellular delivery of potent anti-tumor agents. (C) 2010 Elsevier Ltd. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 7364-7375 |
| Number of pages | 12 |
| Journal | Biomaterials |
| Volume | 31 |
| Issue number | 28 |
| DOIs | |
| Publication status | Published - Oct 2010 |
| Externally published | Yes |
Keywords
- Controlled drug release
- Cytotoxicity
- Drug delivery
- Nanoparticle
- CORE-SHELL NANOPARTICLES
- DRUG-DELIVERY
- IRON CHELATORS
- HYPERBRANCHED POLYMERS
- IN-VITRO
- PLGA NANOPARTICLES
- BLOCK-COPOLYMER
- MICELLES
- CANCER
- DESIGN